Literature DB >> 3545072

Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.

B J Appelmelk, A M Verwey-van Vught, J J Maaskant, W F Schouten, L G Thijs, D M Maclaren.   

Abstract

An antiserum with a high content of antibodies, binding to the Gram-negative lipopolysaccharide core region, was prepared by immunizing rabbits with the rough Escherichia coli mutant J5. This antiserum was capable of protecting mice against lethal challenge doses of E. coli 0 111:B4 in a mouse model where the animals were compromised by means of mucin plus hemoglobin (LD 50 = 10(3) bacteria). However, no protection was observed in a non-compromised mouse model (LD 50 = 10(7) bacteria). This observation might explain why in the past so many discrepant results have been obtained in mouse protection studies with cross-reactive antisera.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545072     DOI: 10.1007/BF00423414

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  22 in total

1.  MUCIN AS A RESISTANCE-LOWERING SUBSTANCE.

Authors:  L Olitzki
Journal:  Bacteriol Rev       Date:  1948-06

2.  EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE.

Authors:  C P Miller
Journal:  Science       Date:  1933-10-13       Impact factor: 47.728

3.  Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.

Authors:  S E Greisman; J B DuBuy; C L Woodward
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

4.  Escherichia coli antibodies in opsonisation and protection against infection.

Authors:  W C van Dijk; H A Verbrugh; M E van Erne-van der Tol; R Peters; J Verhoef
Journal:  J Med Microbiol       Date:  1981-11       Impact factor: 2.472

5.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

6.  Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.

Authors:  L S Young; P Stevens
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.

Authors:  D L Dunn; W C Bogard; F B Cerra
Journal:  Surgery       Date:  1985-08       Impact factor: 3.982

Review 8.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

9.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

10.  Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.

Authors:  R Sakulramrung; G J Domingue
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

View more
  1 in total

1.  Comparative virulence of blood and stool isolates of Shigella sonnei.

Authors:  C Seymour; H M Crowe; M E Wilson
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.